Pharmaceutical

Simcere Zaiming and TargetRx agree TGRX-326 commercial rights

Simcere Zaiming has entered a collaboration deal with Shenzhen TargetRx to bring TGRX-326 to the Chinese market.

Sep 4, 2024 - 04:00
Simcere Zaiming and TargetRx agree TGRX-326 commercial rights
Simcere Zaiming has entered a collaboration deal with Shenzhen TargetRx to bring TGRX-326 to the Chinese market.
Read the original article

Tags:

Previous Article

UK NHS launches vaccine programme for RSV

Next Article

Why the Importer of Record (IoR) is vital in the clinical supply chain ­­

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: No parent who has seen the children I’ve treated for measles would refuse a vaccine

Opinion: No parent who has seen the children I’ve treat...

Mar 13, 2024

Intercept suffers setback with negative AdCom decision for NASH therapy

Intercept suffers setback with negative AdCom decision ...

May 22, 2023

STAT+: Bernie Sanders adds three drug shortage policies to pandemic preparedness bill

STAT+: Bernie Sanders adds three drug shortage policies...

Jul 18, 2023